Group items tagged

Prostate cancer is characterized as the development of the cancer cells in the prostate, a gland in the male reproductive system. Unhealthy diet has been the root cause for many general and severe health problems. A diet that lack Vitamin D makes the individual prone to prostate cancer.

Many newly diagnosed prostate cancers present as low Gleason score tumors that require no treatment intervention. Distinguishing the many indolent tumors from the minority of lethal ones remains a major clinical challenge. We now show that low Gleason score prostate tumors can be distinguished as indolent and aggressive subgroups on the basis of their expression of genes associated with aging and senescence. Using gene set enrichment analysis, we identified a 19-gene signature enriched in indolent prostate tumors. We then further classified this signature with a decision tree learning model to identify three genes-FGFR1, PMP22, and CDKN1A-that together accurately predicted outcome of low Gleason score tumors. Validation of this three-gene panel on independent cohorts confirmed its independent prognostic value as well as its ability to improve prognosis with currently used clinical nomograms. Furthermore, protein expression of this three-gene panel in biopsy samples distinguished Gleason 6 patients who failed surveillance over a 10-year period. We propose that this signature may be incorporated into prognostic assays for monitoring patients on active surveillance to facilitate appropriate courses of treatment.

Medical studies have discovered various factors that enhance the risk of developing prostate cancer. The treatment of prostate cancer can include careful watching and the best ways is to maintain a healthy BMI, cutting down red meat, pan-fried methods of cooking meat, healthy lifestyle with regular exercise and well-balanced diet.

There are many types of cancers, and one of the cancer types that is found among many these days is prostate cancer. In the current scenario, people seem to be quite fast in consuming anti-inflammatory medicines on a regular basis. This increases the probability of prostate cancer.

"Many men as they age will develop prostate cancer and not know it, because it's slow growing and causes no symptoms. Autopsy studies of men who died from other causes have shown that almost 30 percent over the age of 50 have histological evidence of prostate cance"

A new type of stem cell discovered in the prostate of adult mice can be a source of prostate cancer, according to a new study by researchers

In the majority of the cases, prostate cancer grows slowly but the speed of the disease also depends upon the personal health and body composition of the affected individual.

"A study conducted by researchers at cancer centers across the US has found a link between omega-3 fatty acids and an increased risk of prostate cancer. Omega-3 fatty acids are found in fish including salmon, trout, and fresh tuna, and in fish oil supplements. The study, published online July 10 in the Journal of the National Cancer Institute, looked at blood levels of omega-3 fatty acids in some of the men enrolled in the Selenium and Vitamin E Cancer Prevention Trial (SELECT) of more than 35,000 men over age 50 in the US, Puerto Rico, and Canada. The study did not collect information on the men's diets. Therefore, it's not clear whether the omega-3 fatty acids in their blood came from food or from supplements."

"Kathryn Taylor, associate professor in the Cancer Control Program, on conflicting advice about men getting tested for prostate cancer: "We tell men that there's no right or wrong answer [regarding prostate-specific antigen testing] at present, and it really comes down to a personal choice. And the onus, unfortunately, is on them to really educate themselves about the potential benefits as well as the potential harms." American Cancer Society Stands By Cancer Screening Guidelines October 22, 2009, MSN"

A new study by The Institute of Cancer Research, London (ICR) has shown that a genetic test for faults in DNA repair could enable targeted nuclear treatments for patients with prostate cancer.

"The same technology could potentially be used for bladder and multiple myeloma cancers, which also shed identifiable markers in urine. "Our goal is a device the size of a home pregnancy test priced around $10. Other prostate cancer tests coming to market cost up to $4,000 each. The UC Irvine team made price a key design factor of their work..The UC Irvine team developed a new type of sensor: They added nanoscale protein receptors to tiny, pencil-like viruses called phages that live only within bacteria. Double wrapping the phages with additional receptors greatly increases the capture and transmission of cancer molecule signals."